Logo
x

Search category

Subscribe Now

diabetes

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screening & Diagnosis of Chronic Kidney Disease

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screen...

  • November 21, 2022
Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

  • October 26, 2021
PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Ad...

  • September 27, 2021
CVS Dropped Sanofi's Diabetes Drugs Lantus for Biosimilars

CVS Dropped Sanofi's Diabetes Drugs Lantus for Biosimilars

  • August 13, 2021
Viatris and Biocon's Semglee (biosimilar- insulin glargine) Receive the US FDA's Approval as the First Interchangeable Biosimilar for Diabetes

Viatris and Biocon's Semglee (biosimilar- insulin glargine) Receive the US FDA's Approval as the First Interchangeable Biosimilar...

  • July 29, 2021
The US FDA's EMDAC Supports Provention Bio's Teplizumab in Delaying Diabetes

The US FDA's EMDAC Supports Provention Bio's Teplizumab in Delaying Diabetes

  • May 28, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.